journal article·2021-12-16Open access

Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy

Iqra Fatima, Abbas Rahdar, Saman Sargazi, Mahmood Barani, Mohadeseh Hassanisaadi, Vijay Kumar Thakur

Abstract

Breast cancer is becoming one of the main lethal carcinomas in the recent era, and its occurrence rate is increasing day by day. There are different breast cancer biomarkers, and their overexpression takes place in the metastasis of cancer cells. The most prevalent breast cancer biomarker is the human epidermal growth factor receptor2 (HER2). As this biomarker is overexpressed in malignant breast tissues, it has become the main focus in targeted therapies to fight breast cancer. There is a cascade of mechanisms involved in metastasis and cell proliferation in cancer cells. Nanotechnology has become extremely advanced in targeting and imaging cancerous cells. Quantum dots (QDs) are semiconductor NPs, and they are used for bioimaging, biolabeling, and biosensing. They are synthesized by different approaches such as top-down, bottom-up, and synthetic methods. Fully human monoclonal antibodies synthesized using transgenic mice having human immunoglobulin are used to target malignant cells. For the HER2 receptor, herceptin® (trastuzumab) is the most specific antibody (Ab), and it is conjugated with QDs by using different types of coupling mechanisms. This quantum dot monoclonal antibody (QD-mAb) conjugate is localized by injecting it into the blood vessel. After the injection, it goes through a series of steps to reach the intracellular space, and bioimaging of specifically the HER2 receptor occurs, where apoptosis of the cancer cells takes place either by the liberation of Ab or the free radicals.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Biosensing Techniques and Applications · Monoclonal and Polyclonal Antibodies Research · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Quaid-i-Azam University, Islamabad 45320, Pakistan

Department of Physics, University of Zabol, Zabol 98613-35856, Iran

Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 98167-43463, Iran

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman 76169-13555, Iran

Department of Plant Protection, Shahid Bahonar University of Kerman, Kerman 76184-11764, Iran

Biorefining and Advanced Materials Research Center, SRUC, Edinburgh EH9 3JG, UK

School of Engineering, University of Petroleum & Energy Studies (UPES), Dehradun 248007, Uttarakhand, India

References (100+)

Show source-provided references
1. Breast cancer and associated factors: A review
2. Recent Advances in Microbial Toxin-Related Strategies to Combat Cancer
3. Understanding the Cross-Talk between Human Microbiota and Gastrointestinal Cancer for Developing Potential Diagnostic and Prognostic Biomarkers
4. Green Chemistry Approaches for Thiazole Containing Compounds as a Potential Scaffold for Cancer Therapy10.1016/j.scp.2021.100496 ↗
5. Cancer statistics, 200910.3322/caac.20006 ↗
6. Anticancer Property of Lanthanide Sulfate Nanostructure Against Neuroblastoma-Neuro2a Cell Line10.1007/s12668-021-00887-6 ↗
7. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer10.1002/jcp.29584 ↗
8. An eco-benign synthesis of AgNPs using aqueous extract of Longan fruit peel: Antiproliferative response against human breast cancer cell line MCF-7, antioxidant and photocatalytic deprivation of methylene blue10.1016/j.jphotobiol.2018.05.007 ↗
9. The anticancer effect of octagon and spherical silver nanoparticles on MCF-7 breast cancer cell line
10. Waste-grass-mediated green synthesis of silver nanoparticles and evaluation of their anticancer, antifungal and antibacterial activity10.1080/17518253.2018.1444797 ↗
11. Possible Association and Risk Factors of Blastocystis Infection and Colorectal Cancers in Western Iran10.5812/archcid.90861 ↗
12. Structure-function relationships for the EGF/TGF-α family of mitogens10.3109/08977199409010997 ↗
13. Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy10.1158/1078-0432.CCR-06-1732 ↗
14. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene10.1126/science.3798106 ↗
15. Trastuzumab emtansine (T-DM1): A novel agent for targeting HER2+ breast cancer10.1016/j.clbc.2011.03.018 ↗
16. Gold nanoparticles for cancer radiotherapy: A review10.1186/s12645-016-0021-x ↗
17. Evidence-based estimates of the demand for radiotherapy10.1016/j.clon.2014.10.005 ↗
18. The inhibitory effect of Tamarix hispida mediated silver nanoparticles on Cyclin D1 protein expression of human cancer cells line10.1080/24701556.2020.1735432 ↗
19. Cytotoxic activity of biosynthesized Ag nanoparticles by Plantago major towards a human breast cancer cell line10.1007/s12210-017-0641-z ↗
20. Antioxidant, anti-proliferation and cytotoxicity activities of Gossypium hirsutum toward standard HepG2, A549, MCF-7 and U87 cancer cell lines compared to HUVEC, 3T3 normal cells10.9734/EJMP/2017/38160 ↗
21. Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy10.1002/jcp.28967 ↗
22. Gold nanoparticle-mediated bubbles in cancer nanotechnology
23. Methods of Preparation of Metal-Doped and Hybrid Tungsten Oxide Nanoparticles for Anticancer, Antibacterial, and Biosensing Applications10.1016/j.surfin.2021.101641 ↗
24. Combined thermo-chemotherapy of cancer using 1 MHz ultrasound waves and a cisplatin-loaded sonosensitizing nanoplatform: An in vivo study10.1007/s00280-019-03961-9 ↗
25. Curcumin-loaded mesoporous silica nanoparticles/nanofiber composites for supporting long-term proliferation and stemness preservation of adipose-derived stem cells10.1016/j.ijpharm.2020.119656 ↗
26. Application of nanoparticles in cancer therapy with an emphasis on cell cycle10.1002/cbin.11658 ↗
27. Electrochemical nano-biosensors as novel approach for the detection of lung cancer-related MicroRNAs10.2174/1566524019666191001114941 ↗
28. Recent advances in iron oxide nanoparticles for brain cancer theranostics: From in vitro to clinical applications10.1080/17425247.2021.1888926 ↗
29. Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement10.1016/j.nantod.2018.06.008 ↗
30. Gene2vec: Gene subsequence embedding for prediction of mammalian N6-methyladenosine sites from mRNA10.1261/rna.069112.118 ↗
31. Alzheimer’s disease variants with the genome-wide significance are significantly enriched in immune pathways and active in immune cells10.1007/s12035-015-9670-8 ↗
32. MK-FSVM-SVDD: A multiple kernel-based fuzzy SVM model for predicting DNA-binding proteins via support vector data description10.2174/2212392XMTA3bMTYiy ↗
33. Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review10.1007/s11060-021-03729-3 ↗
34. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment10.1039/C6CS00592F ↗
35. A nano-predator of pathological MDMX construct by clearable supramolecular gold (I)-thiol-peptide complexes achieves safe and potent anti-tumor activity10.7150/thno.59020 ↗
36. Reang, J., Sharma, P.C., Thakur, V.K., and Majeed, J. (2021). Understanding the Therapeutic Potential of Ascorbic Acid in the Battle to Overcome Cancer. Biomolecules, 11.10.3390/biom11081130 ↗
37. K-doped ZnO nanostructures: Biosynthesis and parasiticidal application10.1016/j.jmrt.2021.10.137 ↗
38. Zarrabi, A., Zarepour, A., Khosravi, A., Alimohammadi, Z., and Thakur, V.K. (2021). Synthesis of Curcumin Loaded Smart PH-Responsive Stealth Liposome as a Novel Nanocarrier for Cancer Treatment. Fibers, 9.10.3390/fib9030019 ↗
39. Arshad, R., Barani, M., Rahdar, A., Sargazi, S., Cucchiarini, M., Pandey, S., and Kang, M. (2021). Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma. Biosensors, 11.10.3390/bios11040097 ↗
40. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment10.1016/j.sbsr.2021.100417 ↗
41. Rahdar, A., Sargazi, S., Barani, M., Shahraki, S., Sabir, F., and Aboudzadeh, M.A. (2021). Lignin-stabilized doxorubicin microemulsions: Synthesis, physical characterization, and in vitro assessments. Polymers, 13.10.3390/polym13040641 ↗
42. Rahdar, A., Hajinezhad, M.R., Sargazi, S., Zaboli, M., Barani, M., Baino, F., Bilal, M., and Sanchooli, E. (2021). Biochemical, Ameliorative and Cytotoxic Effects of Newly Synthesized Curcumin Microemulsions: Evidence from In Vitro and In Vivo Studies. Nanomaterials, 11.10.3390/nano11030817 ↗
43. Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection10.1016/j.msec.2019.110007 ↗
44. Quantum dots for biomedical delivery applications
45. Semiconductor quantum dots10.1016/j.cossms.2016.06.006 ↗
46. Graphene quantum dots and their applications in bioimaging, biosensing, and therapy10.1002/adma.201904362 ↗
47. Antibody–ProteinA conjugated quantum dots for multiplexed imaging of surface receptors in living cells10.1039/c0mb00056f ↗
48. Monoclonal antibodies in the treatment of metastatic colorectal cancer: A review10.1016/j.clinthera.2010.03.012 ↗
49. Monoclonal antibodies in diagnosis and therapy10.1126/science.2047874 ↗
50. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer10.1200/JCO.2002.20.3.719 ↗
51. Avidin: A natural bridge for quantum dot-antibody conjugates10.1021/ja0125570 ↗
52. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays10.1021/ac010662m ↗
53. Tracking bio-molecules in live cells using quantum dots10.1002/jbio.200810029 ↗
54. Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications10.1155/2014/852748 ↗
55. Her2 activation mechanism reflects evolutionary preservation of asymmetric ectodomain dimers in the human EGFR family10.7554/eLife.00708 ↗
56. The oncogene HER2: Its signaling and transforming functions and its role in human cancer pathogenesis10.1038/sj.onc.1210477 ↗
57. Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells10.1158/0008-5472.CAN-04-3841 ↗
58. Quantum Dots and it method of preparations-revisited
59. Usage of Carbon Nanotubes in Scanning Probe Microscopes as Probe
60. Reactive ion etched II-VI quantum dots: Dependence of etched profile on pattern geometry10.1143/JJAP.32.6233 ↗
61. Synthesis of CdTe, CdSe and CdTe/CdSe core/shell QDs from wet chemical colloidal method10.1016/j.mssp.2017.06.033 ↗
62. One-step and rapid synthesis of high quality alloyed quantum dots (CdSe–CdS) in aqueous phase by microwave irradiation with controllable temperature10.1016/j.materresbull.2005.05.022 ↗
63. Micro-emulsion under ultrasound facilitates the fast synthesis of quantum dots of CdS at low temperature10.1016/j.ultsonch.2010.04.001 ↗
64. Near-infrared electroluminescent devices based on colloidal HgTe quantum dot arrays10.1063/1.1928321 ↗
65. Gram-scale production of graphene based on solvothermal synthesis and sonication10.1038/nnano.2008.365 ↗
66. Controllable synthesis of ultrasmall CuInSe 2 quantum dots for photovoltaic application10.1039/C4RA04727C ↗
67. Microstructural and optical properties of CdSe/CdS/ZnS core-shell-shell quantum dots10.1364/OE.24.00A350 ↗
68. Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly10.1038/35015043 ↗
69. Raman spectroscopy of electrochemically self-assembled CdS quantum dots10.1063/1.125681 ↗
70. Engineering fully human monoclonal antibodies from murine variable regions10.1016/j.jmb.2009.12.046 ↗
71. Human Monoclonal Antibodies
72. Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries10.1016/j.jneuroim.2010.03.023 ↗
73. A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments
74. scFv antibody: Principles and clinical application10.1155/2012/980250 ↗
75. Monoclonal antibodies: A review of therapeutic applications and future prospects10.4314/tjpr.v16i3.29 ↗
76. Humanization of an anti-p185HER2 antibody for human cancer therapy10.1073/pnas.89.10.4285 ↗
77. The HER-2-targeting antibodies trastuzumab and pertuzumab synergistically inhibit the survival of breast cancer cells10.1158/0008-5472.CAN-03-3856 ↗
78. Trastuzumab: Updated mechanisms of action and resistance in breast cancer
79. Applications of electrochemiluminescence resonance energy transfer between CdSe/ZnS quantum dots and cyanine dye (Cy5) molecules in evaluating interactions and conformational changes of DNA molecules10.1016/j.electacta.2012.10.117 ↗
80. Microwave-assisted synthesis of water soluble thiol capped CdSe/ZnS quantum dots and its interaction with sulfonylurea herbicides10.1016/j.jcis.2014.04.050 ↗
81. Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging10.3233/CBM-2008-4603 ↗
82. Clicking hydrazine and aldehyde: The way to labeling of viruses with quantum dots10.1021/acsnano.5b03256 ↗
83. Bioconjugation of quantum dots: Review & impact on future application10.1016/j.trac.2016.07.008 ↗
84. Hermanson, G.T. (2013). Bioconjugate Techniques, Academic Press.
85. Quantum dots as cellular probes10.1146/annurev.bioeng.7.060804.100432 ↗
86. (Bio) conjugation Strategies Applied to Fluorescent Semiconductor Quantum Dots
87. Biosensing with luminescent semiconductor quantum dots10.3390/s6080925 ↗
88. Understanding the self-assembly of proteins onto gold nanoparticles and quantum dots driven by metal-histidine coordination10.1021/nn404479h ↗
89. Preparation of compact biocompatible quantum dots using multicoordinating molecular-scale ligands based on a zwitterionic hydrophilic motif and lipoic acid anchors10.1038/nprot.2015.050 ↗
90. Immunoglobulin binding (B1) domain mediated antibody conjugation to quantum dots for in vitro and in vivo molecular imaging10.1039/C7CC04966H ↗
91. Polymer-coated quantum dots10.1039/c3nr03949h ↗
92. Compact, polyvalent mannose quantum dots as sensitive, ratiometric FRET probes for multivalent protein–ligand interactions10.1002/anie.201600593 ↗
93. The biotin-(strept) avidin system: Principles and applications in biotechnology10.1093/clinchem/37.5.625 ↗
94. Polymer-coated nanoparticles: A universal tool for biolabelling experiments10.1002/smll.201100608 ↗
95. Avidin-biotin technology in targeted therapy10.1517/17425241003677749 ↗
96. Single quantum dot-based nanosensor for sensitive detection of 5-methylcytosine at both CpG and non-CpG sites10.1039/C7SC04813K ↗
97. Integration of isothermal amplification with quantum dot-based fluorescence resonance energy transfer for simultaneous detection of multiple microRNAs10.1039/C8SC00832A ↗
98. Benoiton, N.L. (2016). Chemistry of Peptide Synthesis, CRC Press.10.1201/9781420027693 ↗
99. Assay of Single-Cell Apoptosis by Ensemble and Single-Molecule Fluorescence Methods: Annexin-V/Polyethylene Glycol-Functionalized Quantum Dots as Probes10.1021/acs.langmuir.8b01749 ↗
100. Quantum dot based luminescent nanoprobes for sigma-2 receptor imaging10.1021/acs.molpharmaceut.7b00825 ↗